Mitral Valve Disease: Is TEER Enough for Your Program?
Presenter
Amit N. Vora, M.D., FSCAI, Yale School of Medicine, New Haven, CT
Amit N. Vora, M.D., FSCAI, Yale School of Medicine, New Haven, CT
Learning Objectives:
- Identify when MR is treatable by TEER
- Debate if MAC impacts ability to treat mitral disease
- Discuss anatomic findings which limit success of TEER, and when TEER is not feasible, what percutaneous approaches are available?
Keywords: Cath Lab Administration, Cath Lab Leadership Boot Camp and Training and Professional Development